Accelerate Diagnostics, Inc. announced that it has entered into a securities purchase agreement to issue 33,332 units at a price of $1.5 per unit for the gross proceeds of $49,998 and 2,716,763 units at a price of $1.73 per unit for the gross proceeds of $4,699,999.99 for the total gross proceeds of $4,749,996 on January 19, 2024. The transaction will include participation from individual investors, Chief Executive Officer and Chief Financial Officer for $49,998 and returning investor, Jack W. Schuler Living Trust for $4,749,996. The transaction became effective as of May 20, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.145 USD | -2.14% |
|
0.00% | -70.66% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-70.66% | 27.63M | |
-0.12% | 205B | |
+3.42% | 178B | |
+31.02% | 158B | |
+32.13% | 112B | |
+1.79% | 64.58B | |
+22.50% | 55.34B | |
-3.27% | 46.64B | |
-10.30% | 36.78B | |
-0.88% | 34.85B |
- Stock Market
- Equities
- AXDX Stock
- News Accelerate Diagnostics, Inc.
- Accelerate Diagnostics, Inc. announced that it expects to receive $4.749998 million in funding from Jack W. Schuler Living Trust